Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.
Tokura M, Ando MM, Kojima Y, Kitadai R, Yazaki S, Atutubo CMN, Li RK, Perez MZ, Gorospe AE, Madrid MA, Ordinario MVC, Imasa MSB, Sudo K, Shimoi T, Suto A, Kohsaka S, Machida R, Sadachi R, Yoshida M, Yatabe Y, Hata T, Nakamura K, Yonemori K, Shiino S.
Tokura M, et al. Among authors: kojima y.
Breast Cancer (Auckl). 2024 Oct 27;18:11782234241288671. doi: 10.1177/11782234241288671. eCollection 2024.
Breast Cancer (Auckl). 2024.
PMID: 39493594
Free PMC article.